ÂÜÀòÂÒÂ×

Carlo Incerti is a seasoned professional in the biotechnology and pharmaceutical sectors, currently serving as a Board Member at Dyne Therapeutics and Chairman of the Board at Numab Therapeutics AG, VectorY, and AZAFAROS B.V. From January 2019, Carlo has been an Operating Partner at Forbion and held multiple chairman roles at EryDel S.p.A., Inversago Pharma, and MolMed until 2020. Carlo also contributed to EuropaBio and Gotham Therapeutics as a member of the Board of Directors. Educational qualifications include a Doctor of Medicine degree and board certifications in Endocrinology, Hygiene, Public Health, and Preventative Medicine from Università degli Studi di Modena e Reggio Emilia.